Percutaneous mechanical circulatory support
MCS devices · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Temporary mechanical circulatory support devices (intra-aortic balloon pump, Impella, VA-ECMO) unload the ventricle and maintain systemic perfusion in refractory cardiogenic shock as a bridge to recovery, decision or definitive therapy. Device selection depends on the degree of support needed, the failing ventricle and the need for oxygenation.
Red flags
- Rising lactate despite maximal support (inadequate device flow)
- Limb ischaemia at the cannulation site
- LV distension / pulmonary oedema on VA-ECMO
- Device thrombosis or haemolysis
- Uncontrolled bleeding on anticoagulation
Assessment
Differential diagnosis
- Acute MI cardiogenic shock
- Fulminant myocarditis
- Decompensated cardiomyopathy
- Post-cardiotomy shock
- Massive PE with RV failure
- Refractory arrhythmic shock
Investigations
- Echocardiography (ventricular function, valves, tamponade)
- Coronary angiography where ischaemic
- Lactate and end-organ perfusion markers
- Cardiac output / haemodynamic monitoring
- ABG (oxygenation needs guide device)
- Vascular access assessment (peripheral arterial disease)
Management
- Confirm refractory cardiogenic shock despite inotropes/vasopressors and identify the dominant failing ventricle and whether oxygenation support is needed
- Treat the underlying cause in parallel (revascularise MI, anticoagulate/reperfuse PE)
- Choose device by support requirement: IABP for modest afterload reduction/coronary augmentation; Impella for direct LV unloading and higher flow; VA-ECMO for biventricular failure or when oxygenation support is required
- For isolated RV failure consider a dedicated RV support device or VA-ECMO
- Insert with specialist/cardiology input and vascular access planning; confirm position on imaging
- Set and titrate device support to perfusion targets while weaning catecholamines
- Anticoagulate per device protocol and monitor closely
- On VA-ECMO watch for LV distension and consider venting/unloading (e.g. adding Impella - ECPELLA) to protect the lung and heart
- Monitor for limb ischaemia with femoral cannulae; consider a distal perfusion cannula
- Monitor haemolysis, bleeding, device position and end-organ recovery daily
- Define goals of support early (bridge to recovery, transplant, VAD, or decision) with the heart team
- Plan weaning as ventricular function recovers, with echo-guided support reduction
Drugs & doses
Unfractionated heparin infusion titrated to device-specific targets
Noradrenaline / adrenaline to maintain perfusion while weaning
Dobutamine or milrinone for residual inotropy
Platelet/factor support for device-related bleeding as needed
Disposition
Cardiac ICU at a centre with cardiology, cardiac surgery and ECMO capability; early heart-team involvement for exit strategy.
Complications & pitfalls
- Limb ischaemia and compartment syndrome
- Bleeding and haemolysis
- Thromboembolism / stroke
- LV distension and pulmonary oedema (VA-ECMO)
- Device malposition or failure
- Infection
Exam pearls
- Match the device to the problem: IABP for modest support, Impella for LV unloading, VA-ECMO for biventricular failure or when oxygenation is needed
- VA-ECMO can distend the LV - watch for pulmonary oedema and consider venting (ECPELLA)
- Femoral VA-ECMO/Impella risks limb ischaemia - monitor the distal limb and place a perfusion cannula
- Define the exit strategy (bridge to what) before or at the time of implantation
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.